APA (7th ed.) Citation

M, B., C, G., C, E., V, P., P, J., M, L., . . . C, B. (2024). Myeloperoxidase and N-terminal proatrial natriuretic peptide as predictors for atrial fibrillation recurrence in patients undergoing redo ablation. Heart rhythm O2, 5(11), 770. https://doi.org/10.1016/j.hroo.2024.09.003

Chicago Style (17th ed.) Citation

M, Bannehr, Georgi C, Edlinger C, Paar V, Jankowska P, Lichtenauer M, Haase-Fielitz A, Seifert M, and Butter C. "Myeloperoxidase and N-terminal Proatrial Natriuretic Peptide as Predictors for Atrial Fibrillation Recurrence in Patients Undergoing Redo Ablation." Heart Rhythm O2 5, no. 11 (2024): 770. https://doi.org/10.1016/j.hroo.2024.09.003.

MLA (9th ed.) Citation

M, Bannehr, et al. "Myeloperoxidase and N-terminal Proatrial Natriuretic Peptide as Predictors for Atrial Fibrillation Recurrence in Patients Undergoing Redo Ablation." Heart Rhythm O2, vol. 5, no. 11, 2024, p. 770, https://doi.org/10.1016/j.hroo.2024.09.003.